日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mitochondria-transliterated ALDH1L1 functions as a feedback regulator of redox homeostasis in cancer cells to enhance the resistance to pro-oxidative therapy.

线粒体转译的 ALDH1L1 在癌细胞中作为氧化还原稳态的反馈调节器发挥作用,以增强对促氧化疗法的抵抗力。

Wu Dan, Zhao Xin, Shi Caiyu, Zhao Jing, Yan Zeyu, Zhang Runjiao, Lan Xianchun, An Jiaze, Huang Qichao, He Xianli, Ren Tingting, Xing Jinliang

Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β pathway.

靶向 KAT8 可通过调节 INHBA/TGF-β 通路缓解血管衰老。

Lin Zhongxiao, Xiong Jianyu, Zhang Fuyuan, Zhang Hao, Zhu Menglin, Li Caiyu, Fu Rong, Zhang Zhongyi, Hu Qinwen, Liang Jie, Fu Bohan, Ma Chiyuan, Jin Kehan, Lu Liuyi, Zheng Junmeng, Tomlinson Brian, Yu Xi-Yong, Zhu Yi Zhun

Intensive Blood Pressure Control and Cardiovascular Outcomes Across Cardiovascular-Kidney-Metabolic Syndrome Stages: A Post Hoc Analysis of the China Rural Hypertension Control Project

强化血压控制与心血管-肾脏-代谢综合征各阶段心血管结局:中国农村高血压控制项目的事后分析

Guo, Xiaofan; Zhou, Shiyu; Mu, Jianjun; Zhao, Chunxia; Sun, Guozhe; Zhou, Ying; Yu, Yao; Tan, Xiangyu; Yin, Yangzhi; Xie, Ziyi; Miao, Wei; Li, Wenhang; Zhang, Caiyu; He, Chenhua; Chen, Jie; Tian, Xiaoxuan; Li, Tianhao; Chen, Yifei; Zhou, Xiaobing; Lu, Mengling; Li, Qiyu; Ye, Ning; Li, Guangxiao; Sun, Yingxian

Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trial

强化血压控制对伴或不伴代谢功能障碍相关脂肪肝患者的心血管结局:CRHCP试验的事后分析

Liu, Songyue; Yin, Yangzhi; Yang, Hongmei; Sun, Lufan; Wang, Jun; Zhou, Ying; Guan, Lin; Xing, Liying; Xie, Ziyi; Ye, Ning; Yang, Chuan; Miao, Wei; Zhou, Shiyu; Yu, Yao; Li, Zhi; Tan, Xiangyu; Zhang, Caiyu; He, Chenhua; Liu, Yueting; Chen, Yifei; Sun, Guozhe; Guo, Xiaofan

Tecovirimat-Related Substance: Characterization, Hirshfeld Analysis, Theoretical Study, In Silico Toxicity Assessment

Tecovirimat相关物质:表征、Hirshfeld分析、理论研究、计算机毒性评估

Wang, Fengfeng; Hu, Xiaowen; Zhang, Caiyu; Luan, Lin; Zhou, Zhengzheng; Liu, Yang

A cell-specific computational framework reveals a pan-cancer hypoxia signature predicting overall survival and ICI response

一种细胞特异性计算框架揭示了一种泛癌缺氧特征,该特征可预测总体生存期和免疫检查点抑制剂(ICI)疗效。

Zhang, Caiyu; Jin, Yitong; Yu, Yifangfei; Chen, Yuling; Yang, Jiayi; Zhang, Jialu; Lu, Qianyi; Jiang, Han; Sun, Yue; Zhang, Yakun; Zhi, Hui; Gao, Yue; Wang, Peng; Ning, Shangwei

S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism

S100P 是一种铁死亡抑制剂,通过重新连接脂质代谢来促进肝细胞癌的发展

Min Yang #, Weiwei Cui #, Xiaoting Lv, Gaozhong Xiong, Caiyu Sun, Haocheng Xuan, Wei Ma, Xiuling Cui, Yeping Cheng, Lihui Han, Bo Chu

Antiviral activity of lipoxygenase against severe fever with thrombocytopenia syndrome virus

脂氧合酶对伴有血小板减少症的发热综合征病毒的抗病毒活性

Li, Shuang; Zheng, Xiaojie; Zhang, Yunfa; Zhang, Lingyu; Yang, Tong; Li, Hao; Zhou, Caiyu; Zhang, Xiao-Ai; Gao, Li-Zeng; Liu, Wei

Screen of FDA-approved drug library identifies vitamin K as anti-ferroptotic drug for osteoarthritis therapy through Gas6.

通过对 FDA 批准的药物库进行筛选,发现维生素 K 可通过 Gas6 成为治疗骨关节炎的抗铁死亡药物

Shi Yifeng, Li Sunlong, Zhang Shuhao, Yu Caiyu, Miao Jiansen, Yang Shu, Chen Yan, Zhu Yuxuan, Huang Xiaoxiao, Zhou Chencheng, Ouyang Hongwei, Zhang Xiaolei, Wang Xiangyang

A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer

基于geMER鉴定的核心驱动基因集揭示了其在泛癌中的潜在驱动机制

Gan, Jing; Wang, Yuncong; Shi, Zhuoran; Hu, Haoyu; Xu, Manyi; Li, Xinrong; Dong, Wenbo; He, Jiaheng; Zhao, Yusen; Zhang, Yakun; Sun, Yue; Zhang, Caiyu; Lu, Qianyi; Ning, Shangwei; Jin, Yan; Zhi, Hui